Sale

Adrenal Crisis Treatment Market

Global Adrenal Crisis Treatment Market Share, Size, Trends, Analysis, Growth, Forecast: By Indication: Primary, Secondary, Tertiary; By Diagnosis Method: Blood Test, ACTH Stimulation Test, Insulin-Induced Hypoglycemia Test, Imaging Tests; By Treatment Method; By Treatment Channel; Regional Analysis; Supplier Landscape; 2024-2032

Global Adrenal Crisis Treatment Market Outlook

The global adrenal crisis treatment market attained a value of USD 6.19 million in 2023. The market is estimated to grow at a CAGR of 5.5% and is expected to reach a value of USD 10 million by 2032. The market growth is expected to be driven by increased awareness about the importance of early diagnosis of congenital disorders.

 

adrenal crisis treatment market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Adrenal Crisis Insights

An adrenal crisis occurs when your adrenal glands do not produce enough of the hormone cortisol. It is a potentially fatal complication of adrenal insufficiency (Addison's disease). The adrenal glands are small and triangle-shaped and located just above each kidney. They produce hormones such as cortisol. Cortisol has an impact on nearly every organ and tissue in the body, some of its functions are as follows:

 

  • Controlling the body's stress response
  • Helping to regulate metabolism
  • Inflammation suppression
  • Blood pressure control
  • Blood sugar control
  • Controlling sleep-wake cycle

 

A lack of blood flow may result from an adrenal crisis (shock). Shock spreads quickly and can harm the organs. An adrenal crisis can kill up to 20% of people in shock, if not treated. Other threatening symptoms include seizures or coma.

 

The following are the most common symptoms of an adrenal crisis:

  • Pain in the Abdomen or on the Side (Flank)
  • Long-Lasting Fatigue
  • Appetite Loss
  • Skin Discoloration (Hyperpigmentation)
  • Weakness
  • Unknown Cause of Weight Loss

 

According to the global adrenal crisis treatment market research report, the market can be categorised into the following segments:

 

adrenal crisis treatment market by segments

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Break Up by Indication

  • Primary
  • Secondary
  • Tertiary

 

Market Break Up by Diagnosis Method

  • Blood Test
  • ACTH Stimulation Test
  • Insulin-induced Hypoglycemia Test
  • Imaging Test

 

Market Break Up by Treatment Method

  • Oral Cortisone
    • Hydrocortisone
    • Fludrocortisone Acetate
  • Intravenous Injections
    • Corticosteroids
    • Saline Solution
    • Sugar (Dextrose)

 

Market by Treatment Channel

  • Public
  • Private

 

Market Break up Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

 

adrenal crisis treatment market by region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Global Adrenal Crisis Epidemiology

Adrenaline crises are uncommon, about 42% of people with adrenal insufficiency will experience an adrenal crisis. Adrenal insufficiencies affect 1 in every 100,000 people in the United States.

 

Globally, primary adrenal insufficiency is estimated to affect 82-144 people per million, with autoimmunity being the most common cause in adults and genetic causes, particularly enzyme defects, being the most common cause in children. Secondary adrenal deficiency is estimated to affect 150-280 people per million. The most common cause is believed to be corticosteroid-induced insufficiency, even though the incidence of clinically relevant deficiency after glucocorticoid discontinuation is widely debated.

 

Adrenal Crisis Treatment Market Drivers

Increased awareness about the importance of early diagnosis of congenital disorders is expected to drive the adrenal insufficiency treatment market during the forecast period. Acquired adrenal insufficiency is expected to grow at a faster rate during the forecast period due to an increase in the risk of trauma cases caused by a variety of factors, such as road injuries, war-related trauma, other accidents, and an increase in global disease burden.

 

Because of drug treatment efficiency, there is a growing global demand for the development of newer and more technologically advanced products. As a result, major market players are investing in research and development programmes to develop new drugs.

 

Asia Pacific to Offer Investment Opportunities to the Global Investors

Improving healthcare infrastructure, rising awareness about the importance of timely diagnosis of underlying disorders such as adrenal insufficiency, and a large patient population are expected to present significant opportunities for the Asia Pacific adrenal crisis treatment market in the near future. Increased public and private healthcare spending in China and India are expected to attract manufacturers to these markets.

 

Therapeutic Landscape

At present, patients with adrenal insufficiency are given oral glucocorticoid replacement treatment, which does not exactly match the normal physiologic cortisol rhythm. Another novel method for treating adrenal insufficiency is continuous subcutaneous hydrocortisone infusion therapy, which is delivered via an insulin pump. During the forecast period, all of these factors are expected to drive the adrenal insufficiency market.

 

Competitive Landscape

The report gives an in-depth analysis of the key players involved in the global market, sponsors manufacturing the therapies, and putting them through trials to get FDA approvals. The companies included in the market are as follows: 

 

  • Takeda Pharmaceutical Company Limited
  • Sandoz International GmbH
  • Pfizer Inc
  • Bristol-Myers Squibb Company
  • Merck KGaA
  • Antares Pharma
  • Mallinckrodt Pharmaceuticals
  • Mylan Pharmaceutical AG
  • eTon Pharmaceuticals

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Indication
  • Diagnosis Method
  • Treatment Method
  • Treatment Channel
  • Region
Breakup by Indication
  • Primary
  • Secondary
  • Tertiary
Breakup by Diagnosis Method
  • Blood Test
  • ACTH Stimulation Test
  • Insulin-Induced Hypoglycemia Test
  • Imaging Tests
Breakup by Treatment Method
  • Oral Corticosteroids
  • Intravenous Injections
Breakup by Treatment Channel
  • Public
  • Private
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter's Five Forces
  • Key Indicators for Demand
  • Key Indicators for Price
  • Industry Events, Initiatives, and Trends
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Takeda Pharmaceutical Company Limited
  • Sandoz International GmbH
  • Pfizer Inc
  • Bristol-Myers Squibb Company
  • Merck KGaA
  • Antares Pharma
  • Mallinckrodt Pharmaceuticals
  • Mylan Pharmaceutical AG
  • eTon Pharmaceuticals

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope 
2    Research Methodology
3    Executive Summary
4    Adrenal Crisis Treatment Overview

    4.1    Guidelines and Stages
    4.2    Pathophysiology
    4.3    Screening and Diagnosis
    4.4    Treatment Pathway  
5    Patient Profile
    5.1    Patient Profile Overview 
    5.2    Patient Psychology and Emotional Impact Factors
    5.3    Risk Assessment and Treatment Success Rate
6    Current Scenario Evaluation and Regulatory Framework
    6.1    Emerging Therapies and Clinical Trials Synopsis
    6.2    Patent Landscape 
        6.2.1    Patent Overview
            6.2.1.1    Patent Status and Expiry
            6.2.1.2    Timelines from Drug Development to Commercial Launch
            6.2.1.3    New Drug Application
                6.2.1.3.1    Documentation and Approval Process
    6.3    Cost of Treatment
    6.4    Regulatory Framework
        6.4.1    Regulatory Overview
            6.4.1.1    US FDA
            6.4.1.2    EU EMA
            6.4.1.3    INDIA CDSCO
            6.4.1.4    JAPAN PMDA
            6.4.1.5    Others
7    Challenges and Unmet Needs
    7.1    Treatment Pathway Challenges
    7.2    Compliance and Drop-out Analysis
    7.3    Awareness and Prevention Gaps
8    Global Adrenal Crisis Treatment Market  
    8.1    Global Adrenal Crisis Treatment Market Overview
    8.2    Global Adrenal Crisis Treatment Market Analysis 
        8.2.1    Market Overview
            8.2.1.1    Global Historical Adrenal Crisis Treatment Market Value (2017-2023) 
            8.2.1.2    Global Forecast Adrenal Crisis Treatment Market Value (2024-2032)
        8.2.2    Global Adrenal Crisis Treatment Market by Indication  
            8.2.2.1    Market Overview
                8.2.2.1.1    Primary
                8.2.2.1.2    Secondary
                8.2.2.1.3    Tertiary
        8.2.3    Global Adrenal Crisis Treatment Market by Diagnosis Method  
            8.2.3.1    Market Overview
                8.2.3.1.1    Blood Test
                8.2.3.1.2    ACTH Stimulation Test
                8.2.3.1.3    Insulin-Induced Hypoglycemia Test
                8.2.3.1.4    Imaging Tests
        8.2.4    Global Adrenal Crisis Treatment Market by Treatment Method
            8.2.4.1    Market Overview
                8.2.4.1.1    Oral Corticosteroids
                    8.2.4.1.1.1    Hydrocortisone 
                    8.2.4.1.1.2    Fludrocortisone acetate
                8.2.4.1.2    Intravenous Injections
                    8.2.4.1.2.1    Corticosteroids
                    8.2.4.1.2.2    Saline Solution
                    8.2.4.1.2.3    Sugar (dextrose)
    8.3    Global Adrenal Crisis Treatment Market by Treatment Channel
        8.3.1    Public
        8.3.2    Private
    8.4    Global Adrenal Crisis Treatment Market by Region
        8.4.1    Market Overview
            8.4.1.1    North America
            8.4.1.2    Europe 
            8.4.1.3    Asia Pacific
            8.4.1.4    Latin America
            8.4.1.5    Middle East and Africa
9    North America  Adrenal Crisis Treatment Market
    9.1    Market Share by Country
    9.2    United States of America
        9.2.1    Historical Trend (2017-2023)
        9.2.2    Forecast Trend (2024-2032)
    9.3    Canada
        9.3.1    Historical Trend (2017-2023)
        9.3.2    Forecast Trend (2024-2032)
10    Europe Adrenal Crisis Treatment Market
    10.1    Market Share by Country
    10.2    United Kingdom
        10.2.1    Historical Trend (2017-2023)
        10.2.2    Forecast Trend (2024-2032)
    10.3    Germany
        10.3.1    Historical Trend (2017-2023)
        10.3.2    Forecast Trend (2024-2032)
    10.4    France
        10.4.1    Historical Trend (2017-2023)
        10.4.2    Forecast Trend (2024-2032)
    10.5    Italy
        10.5.1    Historical Trend (2017-2023)
        10.5.2    Forecast Trend (2024-2032)
    10.6    Others
11    Asia Pacific Adrenal Crisis Treatment Market
    11.1    Market Share by Country
    11.2    China
        11.2.1    Historical Trend (2017-2023)
        11.2.2    Forecast Trend (2024-2032)
    11.3    Japan
        11.3.1    Historical Trend (2017-2023)
        11.3.2    Forecast Trend (2024-2032)
    11.4    India
        11.4.1    Historical Trend (2017-2023)
        11.4.2    Forecast Trend (2024-2032)
    11.5    ASEAN
        11.5.1    Historical Trend (2017-2023)
        11.5.2    Forecast Trend (2024-2032)
    11.6    Australia
        11.6.1    Historical Trend (2017-2023)
        11.6.2    Forecast Trend (2024-2032)
    11.7    Others
12    Latin America Adrenal Crisis Treatment Market
    12.1    Market Share by Country
    12.2    Brazil
        12.2.1    Historical Trend (2017-2023)
        12.2.2    Forecast Trend (2024-2032)
    12.3    Argentina
        12.3.1    Historical Trend (2017-2023)
        12.3.2    Forecast Trend (2024-2032)
    12.4    Mexico
        12.4.1    Historical Trend (2017-2023)
        12.4.2    Forecast Trend (2024-2032)
    12.5    Others
13    Middle East and Africa Adrenal Crisis Treatment Market
    13.1    Market Share by Country
    13.2    Saudi Arabia
        13.2.1    Historical Trend (2017-2023)
        13.2.2    Forecast Trend (2024-2032)
    13.3    United Arab Emirates
        13.3.1    Historical Trend (2017-2023)
        13.3.2    Forecast Trend (2024-2032)
    13.4    Nigeria
        13.4.1    Historical Trend (2017-2023)
        13.4.2    Forecast Trend (2024-2032)
    13.5    South Africa
        13.5.1    Historical Trend (2017-2023)
        13.5.2    Forecast Trend (2024-2032)
    13.6    Others
14    Global Adrenal Crisis Market Dynamics
    14.1    Market Drivers and Constraints
    14.2    SWOT Analysis
    14.3    Porter’s Five Forces Model
    14.4    Key Demand Indicators 
    14.5    Key Price Indicators
    14.6    Industry Events, Initiatives, and Trends  
    14.7    Value Chain Analysis
15    Global Adrenal Crisis Treatment Market Supplier Landscape
    15.1    Takeda Pharmaceutical Company Limited
        15.1.1    Company Overview
        15.1.2    Product Portfolio
        15.1.3    Demographic Reach and Achievements
        15.1.4    Mergers and Acquisitions
        15.1.5    Certifications
    15.2    Sandoz International GmbH
        15.2.1    Company Overview
        15.2.2    Product Portfolio
        15.2.3    Demographic Reach and Achievements
        15.2.4    Mergers and Acquisitions
        15.2.5    Certifications
    15.3    Pfizer Inc
        15.3.1    Company Overview
        15.3.2    Product Portfolio
        15.3.3    Demographic Reach and Achievements
        15.3.4    Mergers and Acquisitions
        15.3.5    Certifications
    15.4    Bristol-Myers Squibb Company
        15.4.1    Company Overview
        15.4.2    Product Portfolio
        15.4.3    Demographic Reach and Achievements
        15.4.4    Mergers and Acquisitions
        15.4.5    Certifications
    15.5    Merck KGaA
        15.5.1    Company Overview
        15.5.2    Product Portfolio
        15.5.3    Demographic Reach and Achievements
        15.5.4    Mergers and Acquisitions
        15.5.5    Certifications
    15.6    Antares Pharma
        15.6.1    Company Overview
        15.6.2    Product Portfolio
        15.6.3    Demographic Reach and Achievements
        15.6.4    Mergers and Acquisitions
        15.6.5    Certifications
    15.7    Mallinckrodt Pharmaceuticals
        15.7.1    Company Overview
        15.7.2    Product Portfolio
        15.7.3    Demographic Reach and Achievements
        15.7.4    Mergers and Acquisitions
        15.7.5    Certifications
    15.8    Mylan Pharmaceutical AG
        15.8.1    Company Overview
        15.8.2    Product Portfolio
        15.8.3    Demographic Reach and Achievements
        15.8.4    Mergers and Acquisitions
        15.8.5    Certifications
    15.9    eTon Pharmaceuticals
        15.9.1    Company Overview
        15.9.2    Product Portfolio
        15.9.3    Demographic Reach and Achievements
        15.9.4    Mergers and Acquisitions
        15.9.5    Certifications
16    Global Adrenal Crisis Treatment Distribution Model (Additional Insight)
    16.1    Overview 
    16.2    Potential Distributors 
    16.3    Key Parameters for Distribution Partner Assessment 
17    Payment Methods (Additional Insight)
    17.1    Government Funded
    17.2    Private Insurance
    17.3    Out-of-Pocket

 

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

The market growth is expected to be driven by increased awareness about the importance of early diagnosis of congenital disorders.

Poor reimbursement, high treatment costs, and various drug side effects may restrict the market growth.

The market was estimated to reach about a value of USD 6.19 million in 2023.

The market is expected to grow at a CAGR of 5.5% during the forecast period of 2024-2032.

The market is likely to attain a value of USD 10 million by 2032.

The regions involved in this market are North America, Latin America, Asia Pacific, Europe, and Latin America.

In the event of an adrenal crisis, an intravenous or intramuscular injection of hydrocortisone (an injectable corticosteroid) must be administered right away.

ACTH Stimulation Analysis is the most accurate test for determining adrenal insufficiency.

The key companies involved in the market are Takeda Pharmaceutical Company Limited, Sandoz International GmbH, Pfizer Inc, Bristol-Myers Squibb Company, Merck KGaA, Antares Pharma, Mallinckrodt Pharmaceuticals, Mylan Pharmaceutical AG, and eTon Pharmaceuticals, among others.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER